Chemotherapy-induced cardiotoxicity - PubMed (original) (raw)

Review

Chemotherapy-induced cardiotoxicity

Amir Y Shaikh et al. Curr Heart Fail Rep. 2012 Jun.

Abstract

Anthracycline-based chemotherapeutics have long been recognized as effective agents for treating a wide range of malignancies. However, their use is not without significant adverse cardiotoxic side effects. Strategies for prevention involve limiting free-radical production and subsequent cardiac myocyte damage. Dexrazoxane remains the most widely studied cardioprotective medication. Alternative agents may reduce cardiotoxicity but may still cause significant cardiovascular problems. The role of β-blockers and angiotensin-converting enzyme inhibitors in the treatment of heart failure is well proven. The role of these medications in the prevention and treatment of chemotherapy-induced cardiotoxicity is not well established.

PubMed Disclaimer

Similar articles

• Exposure to anthracyclines during childhood causes cardiac injury.
  Lipshultz SE. Lipshultz SE. Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019. Semin Oncol. 2006. PMID: 16781284 Review.
• Anthracycline-related cardiotoxicity in childhood cancer survivors.
  Lipshultz SE, Karnik R, Sambatakos P, Franco VI, Ross SW, Miller TL. Lipshultz SE, et al. Curr Opin Cardiol. 2014 Jan;29(1):103-12. doi: 10.1097/HCO.0000000000000034. Curr Opin Cardiol. 2014. PMID: 24284979 Review.
• [Chemotherapeutics-induced heart failure].
  Paulides M, Wojnowski L. Paulides M, et al. Med Klin (Munich). 2007 Jul 15;102(7):574-8. doi: 10.1007/s00063-007-1071-y. Med Klin (Munich). 2007. PMID: 17634876 Review. German.
• Cardiac complications in childhood cancer survivors treated with anthracyclines.
  Franco VI, Lipshultz SE. Franco VI, et al. Cardiol Young. 2015 Aug;25 Suppl 2:107-16. doi: 10.1017/S1047951115000906. Cardiol Young. 2015. PMID: 26377717 Review.
• Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy.
  Dozic S, Howden EJ, Bell JR, Mellor KM, Delbridge LMD, Weeks KL. Dozic S, et al. Cells. 2023 May 4;12(9):1312. doi: 10.3390/cells12091312. Cells. 2023. PMID: 37174712 Free PMC article. Review.

Cited by

• Cardiotoxicity associated with targeted cancer therapies.
  Chen ZI, Ai DI. Chen ZI, et al. Mol Clin Oncol. 2016 May;4(5):675-681. doi: 10.3892/mco.2016.800. Epub 2016 Mar 3. Mol Clin Oncol. 2016. PMID: 27123262 Free PMC article.
• Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population.
  Grela-Wojewoda A, Püsküllüoğlu M, Sas-Korczyńska B, Zemełka T, Pacholczak-Madej R, Wysocki WM, Wojewoda T, Adamczyk A, Lompart J, Korman M, Mucha-Małecka A, Ziobro M, Konduracka E. Grela-Wojewoda A, et al. Cancers (Basel). 2022 Jul 10;14(14):3353. doi: 10.3390/cancers14143353. Cancers (Basel). 2022. PMID: 35884413 Free PMC article.
• Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention.
  Bhagat A, Kleinerman ES. Bhagat A, et al. Adv Exp Med Biol. 2020;1257:181-192. doi: 10.1007/978-3-030-43032-0_15. Adv Exp Med Biol. 2020. PMID: 32483740 Review.
• Fluorescence properties of doxorubicin in PBS buffer and PVA films.
  Shah S, Chandra A, Kaur A, Sabnis N, Lacko A, Gryczynski Z, Fudala R, Gryczynski I. Shah S, et al. J Photochem Photobiol B. 2017 May;170:65-69. doi: 10.1016/j.jphotobiol.2017.03.024. Epub 2017 Mar 30. J Photochem Photobiol B. 2017. PMID: 28390260 Free PMC article.
• Protective effects of valsartan administration on doxorubicin‑induced myocardial injury in rats and the role of oxidative stress and NOX2/NOX4 signaling.
  Cheng D, Chen L, Tu W, Wang H, Wang Q, Meng L, Li Z, Yu Q. Cheng D, et al. Mol Med Rep. 2020 Nov;22(5):4151-4162. doi: 10.3892/mmr.2020.11521. Epub 2020 Sep 17. Mol Med Rep. 2020. PMID: 33000246 Free PMC article.

References

1. 1. J Heart Lung Transplant. 2005 Dec;24(12):2196-201 - PubMed
2. 1. J Clin Oncol. 2001 Mar 1;19(5):1444-54 - PubMed
3. 1. J Cancer Res Clin Oncol. 2006 Feb;132(2):121-8 - PubMed
4. 1. N Engl J Med. 1998 Sep 24;339(13):900-5 - PubMed
5. 1. Ann Intern Med. 1993 Jan 1;118(1):31-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information